PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website and mobile app; telephone contact center; and direct mail/print through catalogs, brochures, and postcards. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
IPO Year:
Exchange: NASDAQ
Website: 1800petmeds.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/25/2023 | $20.00 | Buy | Lake Street |
| 1/25/2022 | $25.00 → $21.00 | Underweight | Morgan Stanley |
| 1/20/2022 | $32.00 | Neutral → Buy | Sidoti |
| 11/18/2021 | $25.00 | Underweight | Morgan Stanley |
| 10/1/2021 | $28.00 | Hold | Jefferies |
| 8/5/2021 | $22.00 | Underperform | Credit Suisse |
8-K - PETMED EXPRESS INC (0001040130) (Filer)
NT 10-K - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
10-Q - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
SCHEDULE 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
8-K/A - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
8-A12B - PETMED EXPRESS INC (0001040130) (Filer)
10-Q - PETMED EXPRESS INC (0001040130) (Filer)
Lake Street initiated coverage of PetMed Express with a rating of Buy and set a new price target of $20.00
Morgan Stanley reiterated coverage of PetMed Express with a rating of Underweight and set a new price target of $21.00 from $25.00 previously
Sidoti upgraded PetMed Express from Neutral to Buy and set a new price target of $32.00
Morgan Stanley initiated coverage of PetMed Express with a rating of Underweight and set a new price target of $25.00
Jefferies initiated coverage of PetMed Express with a rating of Hold and set a new price target of $28.00
Credit Suisse resumed coverage of PetMed Express with a rating of Underperform and set a new price target of $22.00
Sidoti downgraded PetMed Express from Buy to Neutral and set a new price target of $39.00
Sidoti upgraded PetMed Express from Neutral to Buy
Sidoti upgraded PetMed Express from Neutral to Buy
Sidoti downgraded PetMed Express from Buy to Neutral